C10 (Capric Acid)
Also known as: C10, decanoic acid, Capric acid
Overview
Capric acid (C10), also known as decanoic acid, is a saturated medium-chain fatty acid (MCFA) containing 10 carbon atoms. It is naturally present in various dietary sources such as coconut oil, palm kernel oil, and dairy fats, and is a key component of medium-chain triglyceride (MCT) oils commonly used as dietary supplements. C10 is primarily utilized in ketogenic diets, particularly for conditions like epilepsy, and is also explored for its potential in cognitive enhancement and metabolic support. Its key characteristic is rapid absorption and metabolism, leading to the production of ketone bodies. However, emerging research suggests that C10 may also exert direct biological effects independent of ketone production, particularly in the brain. While research on C10 is ongoing, with a significant body of animal studies, human data on isolated C10 are still limited, with most clinical evidence stemming from broader MCT mixtures. The overall quality of evidence is moderate, highlighting the need for more targeted human randomized controlled trials.
Benefits
Capric acid (C10) has demonstrated several potential benefits, primarily observed in animal models, with some implications for human health: * **Anticonvulsant Effects:** Murine studies indicate that a diet enriched with MCTs containing C10 significantly reduces seizure activity. This effect appears to be specific to C10, as caprylic acid (C8) did not show similar efficacy, suggesting C10's anticonvulsant properties might be mediated by its accumulation in the brain rather than solely by ketone body production. This finding is particularly relevant for epilepsy research. * **Neurobehavioral Effects:** In mice, both acute and chronic oral administration of C10 has been shown to influence locomotor activity and reduce depression-like behaviors. While some behavioral changes did not reach full statistical significance, these findings suggest a potential role for C10 in modulating mood and behavior. * **Cognitive Support:** Although the effects of isolated C10 on cognition are not yet fully clarified, broader MCT supplementation (which includes C10) has shown promise in improving cognitive function, especially in individuals with mild cognitive impairment who are APOE ɛ4 negative. This suggests C10 may contribute to the overall cognitive benefits observed with MCTs. * **Antioxidant Effects:** Research indicates that C10 may enhance plasma antioxidant capacity and upregulate antioxidant enzymes in the hippocampus. This potential to combat oxidative stress could contribute to its neuroprotective properties, supporting brain health.
How it works
Capric acid (C10) is rapidly absorbed and metabolized, but uniquely, it also accumulates in the brain, where it may exert direct biological effects. Unlike some other fatty acids, C10's anticonvulsant properties appear to be independent of ketone body production, suggesting a direct modulation of neuronal excitability. One proposed mechanism involves the activation of mitochondrial uncoupling proteins (UCPs). This activation can increase proton leak across the mitochondrial membrane, which in turn reduces the production of reactive oxygen species (ROS), thereby contributing to neuroprotection. While C10 metabolism does produce ketone bodies like beta-hydroxybutyrate (BHB), which possess neuroactive properties, C10's specific effects, particularly its anticonvulsant action, are thought to be mediated by mechanisms distinct from simple ketogenesis.
Side effects
Human safety data specifically for isolated capric acid (C10) are limited, as most clinical studies involve MCT oils, which are mixtures of C8 and C10. In animal studies, C10 has generally shown no significant adverse effects at the doses tested, although higher doses were associated with dose-dependent reductions in body weight. When consumed as part of MCT oils, C10 is generally well-tolerated. However, mild gastrointestinal side effects are common, especially when initiating supplementation or consuming higher doses. These can include nausea, stomach cramps, diarrhea, and bloating. There are no major drug interactions or contraindications specifically noted for C10. Nevertheless, caution is advised for individuals with metabolic disorders that affect fatty acid metabolism, as their ability to process C10 might be impaired. As with any supplement, it is recommended to start with a low dose and gradually increase it to assess tolerance. Pregnant or breastfeeding individuals and those with pre-existing medical conditions should consult a healthcare professional before using C10 or MCT supplements.
Dosage
Specific human dosing guidelines for isolated capric acid (C10) are not yet well-established due to the limited number of human studies focusing solely on C10. Most available data come from studies on MCT oils, which are mixtures of C8 and C10. Typical recommended doses for MCT oil, providing a combination of C8 and C10, range from 5 to 30 grams per day. In animal studies, behavioral effects of C10 were observed at oral doses ranging from 0.3 to 3.0 mmol/kg over several weeks, with a broader range of 0.1 to 30 mmol/kg used for various investigations. The timing and formulation of C10 can influence its absorption and plasma levels; C10 plasma concentrations typically peak within a few hours after ingestion and then gradually decline. While C10 can be metabolized into ketone bodies, its direct effects may be less dependent on cofactors like adequate carbohydrate intake, which typically influence ketogenesis. Due to the lack of specific human data, it is advisable to follow the dosing recommendations for MCT oils if using a C10-containing product, starting with a lower dose to assess tolerance and gradually increasing as needed.
FAQs
Is C10 effective alone or only as part of MCT?
Evidence, particularly from animal studies, suggests C10 has unique effects, such as anticonvulsant and neuroprotective actions, distinct from other MCT components like C8. However, human data on isolated C10 are currently sparse, with most clinical evidence derived from MCT mixtures.
Does C10 raise ketone levels?
Yes, C10 can be metabolized into ketone bodies, contributing to ketogenesis. However, some of its observed beneficial effects, particularly its anticonvulsant properties, appear to be independent of significant ketone elevation, suggesting direct mechanisms of action.
Are there side effects?
When consumed as part of MCT oils, mild gastrointestinal discomfort (e.g., nausea, diarrhea) is possible, especially at higher doses. Animal studies on isolated C10 have reported a favorable safety profile with no significant adverse effects at tested doses, but human data are limited.
How quickly does C10 act?
In animal models, behavioral effects of C10 have been observed both acutely (within 30 minutes) and chronically (over weeks). In humans, plasma levels of C10 typically peak within a few hours after ingestion, indicating rapid absorption.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8919109/ – This mouse study investigated the acute and chronic effects of capric acid (C10) on locomotor activity and anxiety/depression-like behaviors. It found dose-dependent effects on behavior and body weight, suggesting C10's potential neurobehavioral modulation independent of significant ketosis at lower doses.
- https://onlinelibrary.wiley.com/doi/abs/10.1002/npr2.12226 – This research, likely a companion or follow-up to the previous one, further explores the neurobehavioral effects of C10 in mice. It reinforces findings on C10's influence on locomotion and mood-related behaviors, contributing to the understanding of its direct brain effects.
- https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.934497/full – This review, incorporating animal studies, highlights the anticonvulsant properties of MCTs, specifically emphasizing C10's role. It proposes that C10's efficacy in reducing seizures is linked to its brain accumulation, antioxidant enzyme upregulation, and mitochondrial uncoupling protein activation, rather than solely ketone production.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11314469/ – This systematic review and meta-analysis focused on the acute post-ingestion kinetics of MCTs in humans. It characterized the rapid rise and decline of C10 plasma levels after ingestion, providing valuable pharmacokinetic data, although it noted more extensive data for C8 than isolated C10.
- https://journals.sagepub.com/doi/10.3233/JAD-230406 – This review discusses the role of MCTs in improving cognitive function, particularly in individuals with mild cognitive impairment who are APOE ɛ4 negative. While it highlights the benefits of MCT mixtures, it also points out the current lack of clear evidence for isolated C10's specific cognitive effects in humans.
